OR FILL OUT THIS FORM AND A COUNSELOR WILL GET BACK TO YOU TO ANSWER YOUR QUESTIONS AND HELP YOU LOCATE A DRUG TREATMENT PROGRAM THAT FITS YOUR PARTICULAR NEEDS.
Information Provided By:
Drug Rehab Programs With Partial Hospitalization And Day Treatment category listings in Garwood, New Jersey:
Mount Carmel Guild Behav Healthcare (1 miles from Garwood, New Jersey)
Mount Carmel Guild Behav Healthcare is located at:
108 Alden Street Cranford, NJ. 7016 908-497-3968
Treatment Services: Outpatient, Partial Hospitalization/Day Treatment, Persons With Co-Occurring Mental And Substance Abuse Disorders Payment Options: Self Payment, Medicaid, Medicare, Private Health Insurance
Inroads to Opportunities (2.2 miles from Garwood, New Jersey)
Inroads to Opportunities is located at:
301 Cox Street Roselle, NJ. 7203 908-241-7200
Treatment Services: Partial Hospitalization/Day Treatment, Persons With Co-Occurring Mental And Substance Abuse Disorders, ASL Or Other Assistance For Hearing Impaired, Spanish, Other Languages Payment Options: Self Payment, Medicaid
Research has indicated that methamphetamine abusers have a significantly heightened risk of heart attacks and strokes because of this damage. Scientists who examined data from more than 3 million Texas hospital patients ages 18 to 44 found a link between heart attack and amphetamine use and reported it in 2008 in the journal Drug and Alcohol Dependence.
By 2004 the supply of meth cooked in super labs and smuggled into the U.S. was increased by Mexican drug cartels.
The longer a person abuses meth, the more they need, even to the point of depriving themselves of basic needs such as food and sleep, in order to keep administering the drug to feed their addiction.
Crystal methamphetamine has also been associated with a large percentage of patients diagnosed with HIV within the past ten years.
Some of the physical consequences of crystal meth use for the cardiovascular system are irreversible, even if abusers manage to eventually kick the habit. Blood vessel damage in the brain has been observed among former users even years after they stopped taking the drug. Since scientists cannot yet offer any way to reduce the damage, long-term risks for stroke for these people remain higher than normal.